Furthermore, the functional annotation and pathway enrichment analysis paved the way for deducing the complex molecular basis for glioma, focusing on the PI3K/Akt pathway, signal transduction deregulation, and metabolic reprogramming. This evidence concerns the gene AKT1 and central nervous system cancer.